A new analysis of the SURPASS-3 trial sheds light on how tirzepatide, a medication for type 2 diabetes, influences muscle composition—specifically muscle volume and fat infiltration. Led by Professor Naveed
Continue readingTirzepatide’s Effects on Muscle Composition Overtime
A growing number of individuals are turning to microdosing weight-loss medications in an effort to manage their weight with minimal side effects. This approach, which involves taking significantly lower doses
Continue readingThe Rise of Microdosing Weight-Loss Drugs: Does It Really Work?
Think You’re Eating Enough Fiber? Think Again. Most adults should get 14 grams of fiber per 1,000 calories consumed. That’s about 28 to 34 grams per day for most men.
Continue readingHow Much Fiber Do You Need & Why Aren’t You Getting Enough?
Semaglutide just obtained a new FDA approval aimed at addressing chronic kidney disease (CKD) in patients with Type 2 diabetes. This latest endorsement positions Ozempic as the most widely indicated
Continue readingSemaglutide FDA Approval for Kidney Disease Risk Reduction
After long review, we have decided to make the change from using a 503A compounding pharmacy to a 503B pharmacy and the integration of new advancements in weight loss medications.
In a groundbreaking three-year clinical trial, tirzepatide, a dual-action medication originally developed to treat type 2 diabetes, has shown remarkable efficacy in preventing the onset of the disease. This study,
Continue readingTirzepatide Demonstrates Diabetes Prevention in Landmark Three-Year Study
A clinical trial investigating the experimental weight loss drug retatrutide suggests it may not only prevent the progression of liver disease but potentially reverse it. According to Dr. Arun Sanyal,
Continue readingExperimental Weight Loss Drug Shows Promise in Treating Liver Disease
The U.S. Food and Drug Administration (FDA) has approved Zepbound (Tirzepatide), a weight loss medication as the first prescription treatment specifically for obstructive sleep apnea (OSA) in adults with obesity.
Continue readingFDA Approves Tirzepatide for Treating Obstructive Sleep Apnea in Adults with Obesity
Emerging research suggests that GLP-1 drugs—commonly used for managing diabetes and obesity—may also support brain health. Semaglutide-based drugs like Ozempic and Wegovy, as well as tirzepatide (Zepbound), may provide neuroprotective benefits that go beyond their well-known effects on weight loss. …
Continue readingGLP-1 Drugs like Ozempic May Protect Brain Health.
While GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound and their alternative compounded versions Tirzepatide and Semaglutide, are widely known for their effectiveness in managing type 2 diabetes and aiding
Continue reading3 Additional Benefits of GLP-1 Drugs Beyond Weight Loss